4 completed, 1 withdrawn. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Withdrawn 1 |
Follow Advanced Nonhematologic Malignancies: new trials by email Literature Review of Advanced Nonhematologic Malignancies trials Research Report on Advanced Nonhematologic Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies MLN2480, MLN0128, Alisertib - Advanced Nonhematologic Malignancies | Phase 1 | Completed | Millennium Pharmaceuticals, Inc. | 81 | 2015-01-14 | 2020-02-25 |
| Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies TAK-733 and alisertib - Advanced Nonhematologic Malignancies | Phase 1 | Withdrawn | Millennium Pharmaceuticals, Inc. | 2013-08-01 | 2013-11-01 | |
| A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies TAK-228, TAK-117 - Advanced Nonhematologic Malignancies | Phase 1 | Completed | Millennium Pharmaceuticals, Inc. | 101 | 2013-06-28 | 2019-10-30 |
| A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies TAK-441 - Advanced Nonhematologic Malignancies, Carcinoma, Basal Cell | Phase 1 | Completed | Millennium Pharmaceuticals, Inc. | 34 | 2010-10-01 | 2013-07-02 |
| Study of MLN4924 in Adult Patients With Nonhematologic Malignancies MLN4924 - Advanced Nonhematologic Malignancies | Phase 1 | Completed | Millennium Pharmaceuticals, Inc. | 62 | 2008-04-01 | 2013-07-16 |
Carcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Basal Cell (1) · Neoplasms, Glandular and Epithelial (1)
MLN 8237 (2) · sapanisertib (2) · Cetuximab (1) · Irinotecan (1) · Paclitaxel (1) · TAK 733 (1) · TAK-441 (1) · pevonedistat (1) · serabelisib (1) · tovorafenib (1)
Millennium Pharmaceuticals, Inc. (5)
United States (5) · Spain (2) · United Kingdom (2) · France (1)
PMID 28157218, PMID 31355467, PMID 41687727
2014 (1)